Technology

Stock Of The Day Viking Holdings Cruising Toward New Buy Point

2025-11-24 17:30
807 views
Stock Of The Day Viking Holdings Cruising Toward New Buy Point

IBD Stock Of The Day Stock Of The Day Viking Holdings Cruising Toward New Buy Point Licensing PAOLO CONFINO 12:30 PM ET 11/24/2025 Viking Holdings Viking Holdings VIK $ 68.28 $4.53 7.1% 125% IBD Stock...

  • IBD Stock Of The Day
Stock Of The Day Viking Holdings Cruising Toward New Buy Point FacebookXLinkedInShare Licensing

Viking Holdings Viking Holdings VIK $ 68.28 $4.53 7.1% 125% IBD Stock Analysis Moving toward 65.37 buy point Rallied above 50-day line last week following earnings Other cruise line stocks struggling Composite Rating 86/99 Industry Group Ranking 98/197 Emerging Pattern Flat Base Flat Base One of three positive chart patterns to look for when doing technical analysis. It usually occurs…

Related news

Close-up of unrecognizable woman in casual clothing standing in spacious shopping mall with lights and holding many paper bags

Rate-Cut Hopes Bolster These Stocks. Two Top Buy Points.

8:36 AM ET In afternoon trading, eight of the 12 best-performing industry groups were from the retail sector.

8:36 AM ET In afternoon trading, eight of the 12 best-performing industry groups...

Today's Spotlight

It’s our biggest deal of the year: Join IBD Digital today for only $1/week. Learn how to read key market signals and position your portfolio for the upcoming year. David Ryan’s Ants Indicator spots stocks under heavy accumulation—try it in MarketSurge.

Partner Center

More News

  • Federal Reserve Dow Jones on stock market today Consumer Confidence Dives, Employment Falls, Supporting Fed Cut
  • Tesla model Y, interior steering wheel screen playing games, white seats. 07,17,2023 New York What Musk And Tesla Are Saying About FSD With Weeks To Go Before This Big Deadline
  • biotech stocks

    The antibody drug conjugates market could be worth north of $32 billion by 2033, according to Grand View Research. (© Dave Cutler)

    Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.